Related Experiment Video
Updated: Sep 26, 2025

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
COVID-19 and Acute Kidney Injury: A Systematic Review
Tahereh Sabaghian1, Amir Behnam Kharazmi2, Ali Ansari3
1Clinical Research Development Center, Imam Hossein Educational Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Insights
Acute kidney injury (AKI) is a frequent complication in hospitalized Coronavirus disease 2019 (COVID-19) patients, leading to increased illness severity and mortality. Early detection of comorbidities and renal issues is crucial for improving outcomes.
Area of Science:
- Nephrology
- Infectious Diseases
- Critical Care Medicine
Background:
- Acute kidney injury (AKI) significantly increases mortality in hospitalized Coronavirus disease 2019 (COVID-19) patients.
- Understanding AKI's impact on COVID-19 patients is vital for improving clinical management and patient outcomes.
Approach:
- A systematic review was conducted, searching PubMed/Medline, Web of Science, and Embase for literature up to February 1, 2022.
- Keywords included "COVID-19", "SARS-CoV-2", and "Acute kidney injury" to identify relevant studies.
- Analysis focused on symptoms, complications, and treatments for AKI in COVID-19 patients.
Key Points:
- The review included 44 studies encompassing 114 COVID-19 patients with AKI (mean age 53.6 years).
- Common comorbidities were diabetes, hypertension, and hyperlipidemia; 12 studies reported pre-existing chronic kidney disease (CKD).
- Focal segmental glomerulosclerosis (FSGS) and acute tubular necrosis (ATN) were the most frequent pathological findings, with an average hospital stay of 19 days.
Conclusions:
- AKI frequently complicates COVID-19 hospitalizations, correlating with increased illness severity, longer hospital stays, and poorer prognosis.
- Early identification of comorbidities and renal complications in COVID-19 patients is essential for better outcomes.
- This systematic review highlights the critical need for proactive renal monitoring in COVID-19 patients.
Introduction:
Acute kidney injury (AKI) has been associated with an increased mortality rate among hospitalized patients with Coronavirus disease 2019 (COVID-19). The current review aimed to evaluate the symptoms, complications, and treatments performed to manage AKI in patients with COVID-19.
Methods:
We searched PubMed/Medline, Web of Science, and Embase for the relevant scientific literature published up to February 1, 2022. The following keywords were used: "COVID-19", "SARS-CoV-2", and "Acute kidney injury".
Results:
Forty-four studies with a total number of 114 COVID-19 patients with AKI (Mean age: 53.6 years) were included in our systematic review. The most common comorbidities in patients with COVID-19 suffering from AKI were the history of diabetes, hypertension, and hyperlipidemia. Twelve out of the 44 included studies reported a history of chronic kidney disease (CKD) in this group of patients. Focal segmental glomerulosclerosis (FSGS) and acute tubular necrosis (ATN) were the most common pathological evidence. The average length of hospital stay was 19 days, and the average duration of need for mechanical ventilation was 3 days.
Conclusions:
The current systematic review shows that AKI frequently complicates the course of COVID-19 hospitalizations and is associated with increased severity of illness, prolonged duration of hospitalization, and poor prognosis. Given the extent of the adverse impact of AKI, early detection of comorbidities and renal complications is essential to improve the outcomes of COVID-19 patients.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management

